INTERNATIONAL PATENT: ATROGI AB FILES APPLICATION FOR "COMBINATIONS OF BETA 2-ADRENERGIC RECEPTOR AGONISTS AND SGLT2 INHIBITORS FOR USE IN TREATING HYPERGLYCAEMIA OR A DISORDER CHARACTERIZED BY HYPERGLYCAEMIA"

GENEVA, Sept. 16 -- ATROGI AB (Tomtebodavagen 6171 65 Solna) filed a patent application (PCT/EP2025/056002) for "COMBINATIONS OF BETA 2-ADRENERGIC RECEPTOR AGONISTS AND SGLT2 INHIBITORS FOR USE IN TREATING HYPERGLYCAEMIA OR A DISORDER CHARACTERIZED BY HYPERGLYCAEMIA" on Mar 05, 2025. With publication no. WO/2025/186320, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BENGTSSON, Tore (Gadolinitvagen 10185 94 Vaxholm), PELCMAN, Benjamin (Dobelnsgatan 85113 52 Stockholm)

Abstract: There is provided herein a Beta2-adrenerg...